Center for Cancer Research

Bethesda, Maryland 20892

0 studies enrolling now · 10 studies all time

What they study most

Anal Cancer, Breast Cancer, Cervical Cancer, Esophageal Cancer, Extrahepatic Bile Duct Cancer, Gastric Cancer, Head and Neck Cancer, Liver Cancer, Lung Cancer, Lymphoma, Malignant Mesothelioma, Metastatic Cancer

Studies at this site

• Rational EpigenetiC Immunotherapy for SEcond Line Therapy in Patients With NSCLC: PRECISE Trial — Completed
• ASP-1929 Photoimmunotherapy (PIT) Study in Patients With Recurrent Head/Neck Cancer — Running, not enrolling
• Monoclonal Antibody Therapy in Treating Patients With Recurrent or Refractory Lymphoma — Completed
• Radiolabeled Monoclonal Antibody Followed by Peripheral Stem Cell Transplantation in Treating Patients With Relapsed or Metastatic Breast Cancer — Completed
• Vaccine Therapy in Treating Patients With Advanced or Recurrent Cancer — Completed
• Decitabine in Treating Patients With Unresectable Lung or Esophageal Cancer or Malignant Mesothelioma of the Pleura — Completed
• Erlotinib in Treating Patients With Locally Advanced or Metastatic Breast Cancer — Completed
• Vaccine Therapy Plus Sargramostim and Chemotherapy in Treating Women With Stage II or Stage III Breast Cancer — Completed
• Flavopiridol in Treating Patients With Recurrent or Metastatic Head and Neck Cancer — Completed
• Epirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid Tumor — Completed